Stephen Goldner, Esq. RAC is the FDA regulatory advisor to National Institute of Health. He leads CureLauncher's partnerships with clinical and pharma companies to ensure rapid placement of patients when a clinical trial match is made. He has gotten 230 drugs and medical devices FDA-approved. Mr. Goldner invented the liquid form of methadone, commercialized it and then sold the company to Chesebrough Ponds / Unilever.

David Fuehrer is an innovation expert and has a successful record of new product and service launches globally. David creates CureLauncher's partnerships with support communities to help members enroll in trials. He has managed innovation programs for Pfizer, GE, Dow and others. David has an MBA in Tech Mgmt, from Rochester Institute of Technology and has completed Executive Education at Harvard in Building New Ventures and at MIT in Strategy.